Exact Sciences Corp EXAS:NASDAQ

Last Price$116.34NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/17/19

Today's Change+1.39(1.21%)
Bid (Size)$96.50 (1)
Ask (Size)$117.47 (2)
Day Low / High$114.54 - 116.81
Volume843.0 K

View Biotechnology IndustryPeer Comparison as of 07/17/2019


Exact Sciences Corp ( NASDAQ )

Price: $116.34
Change: +1.39 (1.21%)
Volume: 843.0 K
4:00PM ET 7/17/2019

Biomarin Pharmaceutical Inc ( NASDAQ )

Price: $82.47
Change: +0.10 (0.12%)
Volume: 703.5 K
4:00PM ET 7/17/2019

Incyte Corp ( NASDAQ )

Price: $80.23
Change: +0.35 (0.44%)
Volume: 904.0 K
4:00PM ET 7/17/2019

Sarepta Therapeutics Inc ( NASDAQ )

Price: $154.00
Change: +0.75 (0.49%)
Volume: 686.1 K
4:00PM ET 7/17/2019

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

Read more news Recent News

Exact Sciences, Mayo Clinic Collaboration Find Potential High-Sensitivity Biomarker for Pancreatic Cancer
10:12AM ET 5/20/2019 MT Newswires

A collaboration between Exact Sciences (EXAS) and the Mayo Clinic in identifying cancer biomarkers may have shown a way to potentially detect the most...

Exact Sciences Says New Data Reinforces Performance of Cologuard in Colorectal Cancer Screening
6:24AM ET 5/17/2019 MT Newswires

Exact Sciences (EXAS) said Friday that new research conducted by the company together with the Mayo Clinical demonstrated the ability of Cologuard to both...

MTNewswires After-Hours News Movers
5:52PM ET 4/30/2019 MT Newswires

Some of the stocks moving on news-driven events in Tuesday's after-hours include: STAF, +16.36% ARLO, +12.34% NUS, +10.58% TNDM, +7.64% AAPL, +4.65% VCYT,...

Exact Sciences Posts Wider-Than-Expected Q1 Loss; Revenue Tops
5:19PM ET 4/30/2019 MT Newswires

Exact Sciences (EXAS) shares fell more than 3% in extended trading on Tuesday after the molecular diagnostics company reported a wider-than-estimated Q1...

Company Profile

Business DescriptionEXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI. View company web site for more details
Address441 Charmany Drive
Madison, Wisconsin 53719
Number of Employees1,977
Recent SEC Filing06/27/201911-K
Chairman, President & Chief Executive OfficerKevin T. Conroy
Senior Vice President-OperationsAna Hooker
Chief Financial OfficerJeffrey T. Elliott
Co-Chief Medical Officer & Head-Medical AffairsBarry M. Berger

Company Highlights

Price Open$115.05
Previous Close$116.34
52 Week Range$47.78 - 121.98
Market Capitalization$15.0 B
Shares Outstanding129.1 M
SectorHealth Technology
Next Earnings Announcement07/30/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.76
Beta vs. S&P 500N/A
Revenue$454.5 M
Net Profit Margin-41.58%
Return on Equity-29.98%

Analyst Ratings as of 07/05/2019

Consensus RecommendationConsensus Icon
Powered by Factset